|Page (1) of 1 - 04/20/17||email article||print page|
(April 20, 2017)
The latest market report published by Credence Research “Global Breast Biopsy Devices Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 - 2022,” the breast biopsy devices market was valued at USD 617.62 Mn in 2015, and is expected to reach USD 1,250.71 Mn by 2022, expanding at a CAGR of 10.6% from 2016 to 2022.
Browse the full report Breast Biopsy Devices Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 – 2022 at http://www.credenceresearch.com/report/breast-biopsy-devices-market
Breast cancer is among the most commonly diagnosed non-skin cancer across the world, with among the highest annual mortality. While the incidence of the disease is increasing at alarming rates in the developing markets, the breast cancer survival prognosis is reported to be con tenuously improving this proving development in the trends of early disease diagnosis and treatment outcomes. Pathological detection of breast cancer has evolved a long way until present with biopsy becoming the standard route of disease detection.
With the introduction of minimally invasive biopsy procedures, intimating with fine needle aspiration, the global breast biopsy devices market has witnessed phenomenal growth over the period. Rapidly aging population and the proven correlation of age with the incidence of breast cancer is among the biggest contributors to the breast biopsy devices market.
Alarming disease incidence and technological development resulting in rapid adoption of breast biopsy devices and related solutions are observed to be the major market drivers in the developing regions of the world. Introduction of guidance enabled biopsy systems has further facilitated the market development and assisted in containment of breast cancer incidence.
Market Competition Assessment
Te global breast biopsy devices market is consolidated with a few players dominating the major chunk of the market revenue. Players such as Hologic, Mammotome, C.R. Bar, Inc. are identified and recognized as the global market leaders. Other players such as Argon Medical Devices, Becton Dickinson and Company, Sterylab are the promising market players with their established positions in prime market segments.
Browse the full report at http://www.credenceresearch.com/report/breast-biopsy-devices-market
Key Market Movements
Increased preference for minimally invasive biopsies
Rapid shift towards guided biopsies
Growth in adoption of disposable consumables
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Download Free Sample Report @ http://www.credenceresearch.com/sample-request/57742
Contact Person: Chris Smith, Global Sales Manager
Email: [email protected]
Address:105 N 1st ST #429, SAN JOSE, CA 95103 US
City: SAN JOSE
Country: United States
Related Keywords:Fitness,Health & Medicine,Manufacturing & Industry,Pharmaceuticals & Biotech,U.S,
Related Sites: HTN - Health Technology Net
Related Newsletter: Tutorial Finder , Review Seeker , DMN Newswire Newsletter